Patheon Inc. announces final court approval of arrangement

          Patheon Inc. announces final court approval of arrangement

PR Newswire

TORONTO, March 10, 2014

TORONTO, March 10,  2014 /PRNewswire/  - Patheon Inc.  (TSX: PTI)  ("Patheon") 
announced today that the Ontario  Superior Court of Justice (Commercial  List) 
(the  "Court")  has  issued  a  final  order  approving  Patheon's  previously 
announced statutory plan of arrangement  (the "Arrangement") under the  Canada 
Business Corporations  Act  ("CBCA")   pursuant  to  which  JLL/Delta  Patheon 
Holdings, L.P. ("Newco"),  which is sponsored  by an entity  controlled by  an 
affiliate of  JLL Partners  Inc.  and Koninklijke  DSM N.V.,  will  indirectly 
acquire all of the issued and outstanding restricted voting shares of Patheon.
In issuing the final order, the  Court has determined that the Arrangement  is 
fair and reasonable in accordance with the requirements of the CBCA.

It is expected that  the Arrangement will be  completed on Tuesday, March  11, 
2014, assuming the satisfaction or waiver of certain customary conditions.

About Patheon Inc.

Patheon Inc.is  a leading  provider of  contract development  and  commercial 
manufacturing services to the global pharmaceutical industry for a full  array 
of solid and sterile  dosage forms. Through  the company's recent  acquisition 
ofBanner Pharmacaps - a  market leader in soft  gelatin capsule technology  - 
Patheonnow also includes a proprietary products and technology business.

Patheonprovides the highest  quality products and  services to  approximately 
300 of the  world's leading  pharmaceutical and  biotechnology companies.  The 
company's integrated network consists of 15 locations, including 12 commercial
contract manufacturing  facilities  and  9  development  centers  acrossNorth 
AmericaandEurope.Patheonenables customer  products  to  be  launched  with 
confidence anywhere in the world. For more information visitwww.patheon.com.

Forward-Looking Statements

This press release contains "forward-looking information" or  "forward-looking 
statements"  within  the  meaning  of  applicable  Canadian  securities  laws, 
including statements regarding the proposed transaction and expected timing of
the transaction,  which  forward-looking statements  may  use  forward-looking 
terminology  such  as  "may",   "will",  "expect",  "anticipate",   "believe", 
"continue", "potential", or the negative  thereof or other variations  thereof 
or  comparable  terminology.  Such  forward-looking  statements  may  include, 
without limitation,  statements  regarding  the  completion  of  the  proposed 
transaction and other statements that are not historical facts.

These forward-looking  statements reflect  beliefs and  assumptions which  are 
based on  Patheon's  perception  of current  conditions  and  expected  future 
developments, as well as other factors management believes are appropriate  in 
the  circumstances.  Patheon's  beliefs  and  assumptions  may  prove  to   be 
inaccurate and consequently Patheon's  actual results could differ  materially 
from the expectations set out herein.

While such forward-looking statements are  expressed by Patheon in good  faith 
and believed  by Patheon  to have  a  reasonable basis,  they are  subject  to 
important risks  and uncertainties  including, without  limitation, risks  and 
uncertainties relating  to  the transaction  and  financing thereof,  and  the 
satisfaction or  waiver  of  certain  other  conditions  contemplated  by  the 
arrangement agreement dated November 18, 2013 between Patheon and Newco. As  a 
result of these  risks and  uncertainties, the proposed  transaction could  be 
modified, restructured or  may not  be completed,  and the  results or  events 
predicted in  these  forward-looking  statements may  differ  materially  from 
actual results or events. These forward-looking statements are not  guarantees 
of future  performance,  given  that they  involve  risks  and  uncertainties. 
Patheon is not affirming or adopting  any statements made by any other  person 
in respect of the proposed  transaction and expressly disclaims any  intention 
or obligation to update or revise any forward-looking statements, whether as a
result of new information,  future events or  otherwise, except in  accordance 
with  applicable  securities  laws  or  to  comment  on  expectations  of,  or 
statements made by any other person in respect of the proposed transaction.

Cautionary Statement

No stock exchange,  securities commission  or other  regulatory authority  has 
approved or disapproved the information contained herein.

SOURCE Patheon Inc.

Contact:

Patheon Inc.
Tel: (919) 226-3200
Email:investorrelations@patheon.com
 
Press spacebar to pause and continue. Press esc to stop.